Dr. Allison Harvey
Please check back in August 2026 for Dr. Harvey's availability to mentor graduate students for Fall 2027
https://psychology.berkeley.edu/people/allison-harvey
Allison Harvey is a Professor of Clinical Psychology, Clinical Psychologist (License #PSY 22682) and Director of the Golden Bear Sleep and Mood Research Clinic at the University of California, Berkeley. Her clinical training and Ph.D. were completed in Sydney, Australia (MQU & UNSW). Dr. Harvey then moved to the University of Oxford as a postdoctoral fellow in the Department of Psychiatry and then became a faculty member in the Department of Experimental Psychology at Oxford. She was also a Fellow of St. Anne’s College. In 2004, she moved to UC Berkeley.
Dr. Harvey is the recipient of numerous awards including early career awards from the Association for Behavioral and Cognitive Therapies (ABCT) and NARSAD. More recently, she was the recipient of Lifetime Achievement Awards from both the Sleep Research Society and the Society for Behavioral Sleep Medicine and she received an Honorary Doctorate from the University of Örebro, Sweden. Dr. Harvey has been elected as a Fellow of the Association for Psychological Science and has served on national and international committees including the Executive Committee of the Academy of Psychological Clinical Science and the Review Committee for PCSAS. Dr. Harvey’s research is currently funded by the National Institutes of Health. Dr. Harvey has published over 350 research articles and book chapters and has authored three books.
Dr. Harvey’s team aims to develop more effective and efficient treatments for mental health problems (a) by applying a multi-systems and mechanisms-focused framework in which basic science findings on cognitive, affective, biological, behavioral and developmental contributors are used as sources for deriving novel interventions and (b) by using intervention research to develop hypotheses about and/or confirm mechanisms. We are particularly interested in severe mental illness, sleep, memory, habits, and transdiagnostic approaches.
Treatment development teams often need to take on the challenging task of retooling in the rapidly advancing science of dissemination and implementation (D&I) to ensure the investments made to develop new treatments can be accessed by the people who most need them. Indeed, over the past decade Dr. Harvey and her team have been developing expertise in D&I in partnership with community mental health centers (CMHCs) across California. This research was funded via two R01s awarded by NIMH (MH105513, MH120147). Also, Dr. Harvey was very fortunate to participate in the Training Institute for Dissemination and Implementation Research in Health (TIDIRH) in 2017 conducted by the National Cancer Institute.